Cardiovascular Magnetic Resonance Imaging

Cardiovascular magnetic resonance imaging , Cardiovascular magnetic resonance imaging , کتابخانه مرکزی دانشگاه علوم پزشکی تهران

[1]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[2]  R. Kim,et al.  Rapid Detection of Myocardial Infarction by Subsecond, Free-Breathing Delayed Contrast-Enhancement Cardiovascular Magnetic Resonance , 2006, Circulation.

[3]  Katherine C. Wu,et al.  Neurohumoral features of myocardial stunning due to sudden emotional stress. , 2005, The New England journal of medicine.

[4]  Peter Boesiger,et al.  Improved three‐dimensional free‐breathing coronary magnetic resonance angiography using gadocoletic acid (B‐22956) for intravascular contrast enhancement , 2004, Journal of magnetic resonance imaging : JMRI.

[5]  D. Pennell,et al.  Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.

[6]  René M. Botnar,et al.  Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. , 2007, Radiology.

[7]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[8]  E. McVeigh,et al.  Phase‐sensitive inversion recovery for detecting myocardial infarction using gadolinium‐delayed hyperenhancement † , 2002, Magnetic resonance in medicine.

[9]  J. Carr,et al.  Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. , 2008, Journal of the American College of Cardiology.

[10]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[11]  M. Robson,et al.  Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. , 2007, Journal of the American College of Cardiology.

[12]  H. Halperin,et al.  Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla , 2006, Circulation.

[13]  F. Van de Werf,et al.  Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. , 2009, European heart journal.

[14]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[15]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[16]  R. Kim,et al.  Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.

[17]  Daniel F. Kacher,et al.  Characterization of Human Atherosclerotic Plaques by Intravascular Magnetic Resonance Imaging , 2005, Circulation.

[18]  Mark A Westwood,et al.  Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. , 2006, Haematologica.

[19]  P. Kellman,et al.  Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm , 2006, Journal of magnetic resonance imaging : JMRI.

[20]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[21]  J. Grizzard Magnetic resonance imaging of pericardial disease and intracardiac thrombus. , 2009, Heart failure clinics.

[22]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[23]  K. Durongpisitkul,et al.  Predictors of Successful Transcatheter Closure of Atrial Septal Defect by Cardiac Magnetic Resonance Imaging , 2004, Pediatric Cardiology.

[24]  R. Kwong,et al.  Complementary Prognostic Values of Stress Myocardial Perfusion and Late Gadolinium Enhancement Imaging by Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease , 2009, Circulation.

[25]  J. Felblinger,et al.  Detection of myocarditis by contrast‐enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis , 2007, Journal of magnetic resonance imaging : JMRI.

[26]  D. Pennell,et al.  A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance , 2007, Circulation.

[27]  M. Robson,et al.  Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.

[28]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[29]  M. Horn Cardiac magnetic resonance spectroscopy: a window for studying physiology. , 2006, Methods in molecular medicine.

[30]  Katja Zeppenfeld,et al.  Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.

[31]  Sebastian Kelle,et al.  Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.

[32]  R. Kim,et al.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. , 2009, Heart failure clinics.

[33]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[34]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[35]  Hugh Calkins,et al.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[36]  R. Kim,et al.  Fundamental concepts in myocardial viability assessment revisited: when knowing how much is “alive” is not enough , 2004, Heart.

[37]  R. Kim,et al.  Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial , 2008, Circulation.

[38]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[39]  D. Pennell MRI and iron-overload cardiomyopathy in thalassaemia. , 2006, Circulation.

[40]  D. Kraitchman,et al.  Stem cell therapy: MRI guidance and monitoring , 2008, Journal of magnetic resonance imaging : JMRI.

[41]  J. Gillard,et al.  Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[42]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[43]  Stefan Neubauer,et al.  Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[44]  Petros Syrris,et al.  Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[45]  C. Claussen,et al.  Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. , 2009, JACC. Cardiovascular imaging.

[46]  R. F. Hoyt,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[47]  Diego R Martin,et al.  Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. , 2008, Radiology.

[48]  Matthias Stuber,et al.  Volume‐targeted and whole‐heart coronary magnetic resonance angiography using an intravascular contrast agent , 2009, Journal of magnetic resonance imaging : JMRI.

[49]  Stefan Neubauer,et al.  Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[50]  H. Calkins,et al.  Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. , 2006, Journal of the American College of Cardiology.

[51]  D. Pennell,et al.  The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.

[52]  D. Pennell T2* Magnetic Resonance and Myocardial Iron in Thalassemia , 2005, Annals of the New York Academy of Sciences.

[53]  Chun Yuan,et al.  MRI of atherosclerosis , 2004, Journal of magnetic resonance imaging : JMRI.

[54]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[55]  E. Nagel,et al.  Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes , 2009, Circulation.

[56]  O. Vignaux,et al.  Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. , 2002, Chest.

[57]  Fei Liu,et al.  MRI of atherosclerosis in clinical trials , 2006, NMR in biomedicine.

[58]  Robert G. Weiss,et al.  Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.

[59]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[60]  E P Walsh,et al.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.

[61]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model , 2009, Circulation.

[62]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[63]  R. Muthupillai,et al.  Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction , 2009, Circulation.

[64]  Manesh R. Patel,et al.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. , 2006, Journal of the American College of Radiology : JACR.

[65]  W. Manning,et al.  Coronary magnetic resonance imaging. , 2007, Cardiology clinics.

[66]  C. Hamm,et al.  Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. , 2009, European heart journal.

[67]  E. Fleck,et al.  Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease , 2008, Circulation. Cardiovascular imaging.

[68]  Debiao Li,et al.  Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. , 2009, Journal of the American College of Cardiology.

[69]  S. Sen-Chowdhry,et al.  The utility of magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular cardiomyopathy , 2008, Current opinion in cardiology.

[70]  D. Pennell,et al.  Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[71]  Daniel C. Lee,et al.  Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity , 2004, Circulation.

[72]  Eckart Fleck,et al.  Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.

[73]  S. Priori,et al.  Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[75]  Stefan Neubauer,et al.  Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[76]  Igor Klem,et al.  mproved Detection of Coronary rtery Disease by Stress Perfusion ardiovascular Magnetic Resonance With he Use of Delayed Enhancement Infarction Imaging , 2006 .

[77]  John P Ridgway,et al.  Coronary artery disease: assessment with a comprehensive MR imaging protocol--initial results. , 2002, Radiology.

[78]  Hugh Calkins,et al.  A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. , 2008, The New England journal of medicine.

[79]  R. Cury,et al.  Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department , 2008, Circulation.

[80]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[81]  N. Geller,et al.  Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. , 2006, Journal of the American College of Cardiology.

[82]  Peter Kellman,et al.  ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.

[83]  Fabien Hyafil,et al.  Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. , 2005, Radiology.

[84]  Jürgen Hennig,et al.  Three‐dimensional analysis of segmental wall shear stress in the aorta by flow‐sensitive four‐dimensional‐MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[85]  René M. Botnar,et al.  In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent , 2004, Circulation.

[86]  Idith Haber,et al.  Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot , 2009, Circulation.

[87]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[88]  R. Kwong,et al.  Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction , 2008, Circulation.

[89]  Martin R Prince,et al.  Incidence of nephrogenic systemic fibrosis at two large medical centers. , 2008, Radiology.

[90]  Jeroen J. Bax,et al.  Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. , 2005, Journal of the American College of Cardiology.

[91]  M. Friedrich,et al.  Abnormalities in T2‐weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: Regional distribution and relation to late gadolinium enhancement and severity of hypertrophy , 2008, Journal of magnetic resonance imaging : JMRI.

[92]  A. van Rossum,et al.  MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.

[93]  E. Fleck,et al.  High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. , 2004, Radiology.

[94]  R. Kim,et al.  Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. , 2008, Journal of the American College of Cardiology.

[95]  Scott D Flamm,et al.  Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. , 2009, JACC. Cardiovascular imaging.

[96]  H. Calkins,et al.  Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[97]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent , 2005, Circulation.

[98]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[99]  Saman Nazarian,et al.  How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. , 2009, Heart rhythm.

[100]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[101]  W. Hundley,et al.  Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. , 2009, JACC. Cardiovascular imaging.

[102]  J. Schulz-Menger,et al.  Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.

[103]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[104]  Mark Doyle,et al.  Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: A practical approach , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[105]  K. Nayak,et al.  Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[106]  Horst Olschewski,et al.  Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure , 2008, Circulation. Cardiovascular imaging.

[107]  Chun Yuan,et al.  Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. , 2006, Radiology.